Navigation Links
Evanston-Northwestern Study Proves Effectiveness of MRSA Screening to Reduce Hospital Infections

NEW YORK, March 18 /PRNewswire-USNewswire/ -- A new study in the Annals of Internal Medicine adds weight to the growing evidence that screening incoming hospital patients for the bacterium MRSA (methicillin-resistant Staphylococcus aureus) is effective, and indeed essential, to reduce MRSA hospital infections. The study, published yesterday, resulted in a 70% reduction in MRSA hospital infections at the three hospitals in the Evanston Northwestern Healthcare System, located near Chicago.

This was the first "large scale, universal admission MRSA surveillance program in the United States," researchers reported, but the stunning results are consistent with at least fifty earlier studies showing that it is not possible to stop the spread of drug-resistant bacteria from patient to patient without screening. "To stop MRSA from racing through the hospital, you must know the source, that is, which patients are bringing it in," says Betsy McCaughey, Ph.D., Chairman of the Committee to Reduce Infection Deaths. "Without screening, the germs spread rapidly on equipment, lab coats, blood pressure cuffs, wheel chairs, virtually every surface. Patients who are carrying MRSA unknowingly shed it everywhere, putting the patients around them at risk."

Evanston-Northwestern researchers used a rapid test (average turnaround time from swabbing the patient to receiving test results at bedside was 18 hours). The rapid test enabled caregivers to promptly isolate patients identified as MRSA positive, use gowns, gloves and dedicated or disposable equipment when treating them, and apply mupirocin to their nasal passages and chlorhexidine to their skin to reduce the presence of the bacteria.

"This new study sets the record straight, correcting the misimpression created by an article in the Journal of the American Medical Association on March 12th suggesting that screening for MRSA was ineffective. That previous study, done in one surgical ward of a Geneva Switzerland hospital, "was seriously flawed," according to McCaughey, "rendering its findings insignificant." In that previous study, many patients were not tested until they had been in the hospital twelve hours, and test results were delayed an average of 22.5 hours after that --- a 34.5 hour delay overall. In fact, 41% of patients had already had their surgeries, before their test results were known. Consequently, the precautions, including isolation, that are supposed to be taken in response to an MRSA positive result, were not taken. The delay allowed the germ to spread to other patients.

"The evidence is overwhelming that hospitals cannot effectively prevent the spread of MRSA bacteria if they don't know which patients carry these germs," says McCaughey. "Screening saves lives. The federal Centers for Disease Control and Prevention should call on all hospitals to screen incoming patients for MRSA."

SOURCE Committee to Reduce Infection Deaths
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. MTM Study Reports Improved Quality and Economic Outcomes Using Medication Management Systems Assurance Pharmaceutical Care System(TM)
2. New Healthcare Study Outlines Strategies to Increase Adoption of Home Health Monitoring Technologies
3. Neighborhoods play key role in how much people exercise, study says
4. Study Analyzed Long-Term SYMBICORT(R) Use in Children With Persistent Asthma
5. Cancer detected earlier, faster, with new medical imaging, Stanford study finds
6. Study Finds Potential Cause of Age-Related Macular Degeneration
7. New Study: Pycnogenol(R) Improves Memory in Elderly
8. Researchers study new drug and indications for heated chemotherapy treatment
9. Scripps research team wins $4M grant to study effects of chronic marijuana use
10. Meditation impacts blood pressure, study shows
11. Mayo Clinic study shows Parkinsons disease drug might work in cancer patients
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her son ... lash out at his family verbally and physically. , “When something upset him, he couldn’t ... would use it. He would throw rocks at my other children and say he was ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... ... is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. ... magazine’s Code Talker Award, an essay contest in which patients and their families pay ... be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016 Research and Markets ... for Companion Diagnostic Tests" report to their offering. ... Companion Diagnostics The World Market for Companion ... medicine diagnostics. Market analysis in the report includes the following: ... (In Vitro Diagnostic Kits) by Region (N. America, EU, ROW), ...
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
Breaking Medicine Technology: